INIS
cancer
56%
prostate
52%
tissues
21%
tumors
21%
genes
21%
levels
17%
growth
13%
comparative evaluations
13%
metastases
13%
mice
8%
data
8%
in vivo
8%
vectors
8%
chemotherapy
8%
correlations
4%
drugs
4%
patients
4%
in vitro
4%
proteins
4%
sensitivity
4%
datasets
4%
control
4%
biological markers
4%
values
4%
reduction
4%
messenger-rna
4%
weight
4%
apoptosis
4%
proliferation
4%
growth inhibition
4%
pcr
4%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA 375
100%
Docetaxel
43%
Prostate Cancer
43%
Chemotherapy
26%
Neoplasm
13%
Malignant Neoplasm
13%
Western Blot
13%
Tumor Growth
8%
Overall Survival
4%
Protein
4%
Messenger RNA
4%
Drug Resistance
4%
Enalapril Maleate
4%
Biological Marker
4%
Nude Mouse
4%
Cancer Staging
4%
Lentivirus Vector
4%
microRNA
4%
Mouse
4%
Apoptosis
4%
Immunology and Microbiology
Drug Resistance
21%
Gene
21%
Cells
21%
Prostate
17%
Cell Growth
8%
Cancer Tissue
8%
Prostate Cancer Cell Line
8%
Tissues
8%
Overall Survival
4%
Genetic Transfection
4%
Apoptosis
4%
Electric Potential
4%
Growth Inhibition
4%
Growth Rate
4%
Cancer Cell
4%
Nude Mouse
4%
Growth
4%
Xenograft
4%
Cancer Staging
4%
Development
4%
Lentivirus Vector
4%
Prostate Tissue
4%
Mouse
4%
Reduction (Chemistry)
4%
Weight
4%
Biochemistry, Genetics and Molecular Biology
YAP1
26%
Nested Gene
21%
Drug Resistance
21%
Cell Growth
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Development
4%
Apoptosis
4%
Transfection
4%
Nude Mouse
4%
Electric Potential
4%
Cancer Cell
4%
Growth Inhibition
4%
Overall Survival
4%
Growth
4%
Growth Rate
4%
Lentivirus Vector
4%
Cancer Staging
4%
Mouse
4%
Reduction (Chemistry)
4%
Protein
4%
Messenger RNA
4%
Weight
4%
microRNA
4%